Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
Allen Institute for Brain Science · Memorial Sloan Kettering Cancer Center · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
547
total citations
- FWCI
- 20.44
- Percentile
- 100%
- References
- 50
Citations per year
Authors
10- APAlexander Pietras
Allen Institute for Brain Science, Memorial Sloan Kettering Cancer Center, University of Washington, Fred Hutch Cancer Center
- AKAmanda Katz
Memorial Sloan Kettering Cancer Center
- EEElin Ekström
Memorial Sloan Kettering Cancer Center
- BWBoyoung Wee
Memorial Sloan Kettering Cancer Center
- JJJohn J. Halliday
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- CD44
- Biology
- Osteopontin
- Glioma
- Cancer stem cell
- Stem cell
- Cancer research
- Phenotype
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.